FDA rejects Sunovion’s nebulised COPD drugThe US regulator has rejected Sunovion’s nebulised therapy for chronic obstructive pulmonary disease (COPD), leaving the company struggling Share XFDA rejects Sunovion’s nebulised COPD drughttps://pharmaphorum.com/news/fda-rejects-sunovions-nebulised-copd-drug/
